Your session is about to expire
← Back to Search
Behavioral Intervention
Tweet2Quit for Smoking Cessation (Tweet2Quit Trial)
Phase 2
Waitlist Available
Led By Connie (Cornelia) Pechmann, PhD, MBA, MS
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Lives in the continental USA
Are 21-59 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month
Awards & highlights
Tweet2Quit Trial Summary
This study is evaluating whether a smoking cessation intervention that combines real-time online peer-to-peer support with auto messaging is more effective than usual care.
Tweet2Quit Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTweet2Quit Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of participants with a 6-month sustained abstinence
Secondary outcome measures
Percentage of participants with a 3-month sustained abstinence
Other outcome measures
Percentage of participants with a 7-Day point prevalence abstinence
Tweet2Quit Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: NRT + Web Guide + Tweet2Quit-WomenExperimental Treatment3 Interventions
Experimental: NRT + Web Guide + Tweet2Quit-Women NCI Smokefree.gov plus 8 weeks of combination NRT (nicotine patch plus gum/lozenges) plus assignment to a women-only Tweet2Quit group
Group II: NRT + Web Guide + Tweet2Quit-CoedExperimental Treatment3 Interventions
NCI Smokefree.gov plus 8 weeks of combination NRT (nicotine patch plus gum/lozenges) plus assignment to a coed Tweet2Quit group
Group III: NRT + Web GuideActive Control2 Interventions
NCI Smokefree.gov plus 8 weeks of combination NRT (nicotine patch plus gum/lozenges)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tweet2Quit
2016
Completed Phase 2
~960
NRT
2016
Completed Phase 2
~1260
Web Guide
2016
Completed Phase 2
~960
Find a Location
Who is running the clinical trial?
Stanford UniversityOTHER
2,386 Previous Clinical Trials
17,333,048 Total Patients Enrolled
University of California, IrvineLead Sponsor
542 Previous Clinical Trials
1,921,041 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,193 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger